Beractant
Beractant is a sufactant. Beractant is used to treat lung damage (respiratory distress syndrome) in pre-term infants. Beractant is administered directly to the lungs and can rapidly restore lung compliance. This composite material is designed to mimic surface-tension lowering properties of natural lung surfactant
Primary Characteristics
It is of Natural origin and belongs to .
It is classified in Lubricant pharmacological group. It is also classified under Respiratory Combination Products .
Solubility in Water: null · Solubility in Alcohol: null · Non-proprietary name: Beractant.

Pharmacokinetics
Distribution: Beractant has a volume of distribution is . plasma protein binding is .
Elimination: it is metabolised via , plasma half-life is , renal excretion is .
Advertisement
Indications
Beractant is primarily indicated in conditions like Respiratory distress syndrome.
Contraindications
None recorded.
Dosage
None recorded.
Drug Interactions
None recorded.
Side Effects
Beractant is known to cause more or less tolerable side effects which are usually transient. These include Apnea , Endotracheal tube blockage, Hypercarbia, Hypertension , Hypocarbia, Hypotension , Oxygen desaturation, Pallor, Pulmonary air leaks, Vasoconstriction .
Warnings / Precautions
Available Brands
Click on a strength to view available brands.
Single Ingredient
Storage Conditions
Drug Classification
- 1.25.6 — Respiratory stimulants and pulmonary surfactants
Manufacturers
Manufacturers of Beractant in Pakistan: